Home
 
Web 24x7 Updates
Editor's Note
 

Enzon to Present at Credit Suisse First Boston Healthcare Conference
E-Mail this story Print this story
            Nov 17, 2004 12:10 IST  
Enzon Pharmaceuticals, Inc. (Nasdaq: ENZN) announced today that the company will participate in the Credit Suisse First Boston Healthcare Conference, which is being held November....

Enzon Pharmaceuticals, Inc. (Nasdaq: ENZN) announced today that the company will participate in the Credit Suisse First Boston Healthcare Conference, which is being held November 17-19, 2004 in Phoenix, Arizona. Ken Zuerblis, Enzon’s chief financial officer, will give a 25-minute presentation on Wednesday, November 17, 2004 at 3:30 p.m. MST or 5:30 p.m. EST.

The final schedule can be accessed at http://www.csfb.com/conferences/healthcare/client/agenda.shtml. A live webcast of the presentation may be accessed by visiting Enzon’s website at www.enzon.com. For those unable to listen to the live broadcast, a replay of the webcast will also be available on the Company’s website.

About Enzon

Enzon Pharmaceuticals is a biopharmaceutical company dedicated to the discovery, development and commercialization of therapeutics to treat life-threatening diseases. The Company has developed or acquired a number of marketed products, including PEG-INTRON(R), marketed by Schering-Plough, and ABELCET(R), ONCASPAR(R), ADAGEN(R), and DEPOCYT(R), marketed in North America by Enzon’s specialized sales force. Enzon’s science-driven strategy includes an extensive drug development program that leverages the Company’s macromolecular engineering technology platforms, including PEG modification and single-chain antibody (SCA(R)) technologies. Internal research and development efforts are complemented by strategic transactions that provide access to additional products and technologies. Enzon has several drug candidates in various stages of development, independently and with partners, including Marqibo(R) (formerly referred to as Onco TCS), for which a U.S. marketing application is currently being reviewed by the FDA for the treatment of relapsed aggressive non-Hodgkin’s lymphoma. Further information about Enzon and this press release can be found on the Company’s web site at www.enzon.com.
More Stories
Commercial Viability of Phosphatase Enzyme Class as Therapeutic Targets Analysed   - Nov 17, 2004 11:53 IST
Research and Markets (http://www.researchandmarkets.com/reports/c9232) has announced the addition of Phosphatases: Emerging Role in Signal Transduction, Human Therapeutics, & As Drug Targets to their offering.
Recently, several members of the phosphatase drug target class have been identified and classes of compounds have been screened with hits identified.


``Pass the Potatoes’’ This Holiday Season and Lose Weight   - Nov 17, 2004 11:51 IST
This holiday season, passing the potatoes doesn’t have to mean calorie counting and extra hours at the gym. Lately, potatoes have been a casualty in the carb-free, protein-centric diet craze, but recent clinical data shows that harnessing the power inside the potato can actually be a key component in the struggle to lose and manage weight. Video Available

Current uses of Green-Fluorescent Protein in Biopharmaceutical Industry Examined   - Nov 17, 2004 11:47 IST
Research and Markets (http://www.researchandmarkets.com/reports/c9202) has announced the addition of A Guide to Green-Fluorescent Protein to their offering.
This resource-oriented practical Guide provides an all encompassing overview of the most important features and technological applications of Green-Fluorescent Protein and its variant forms. It seeks to describe Green-Fluorescent Protein’s usefulness in biomedical programs and applications.


New findings may redirect strategies for treatment of prostate cancer   - Nov 17, 2004 11:41 IST
A new research study published in the November issue of Cancer Cell may have important implications for treatment of prostate cancer, the most common malignancy afflicting males in the United States. The research provides significant and somewhat surprising new information about modulation of the androgen receptor (AR), a key determinant of prostate cancer progression and an attractive target for prostate cancer therapies.

Autism may be caused by brain swelling due to immune system reaction   - Nov 17, 2004 11:40 IST
Autism could be caused by an immune system reaction which causes the brain to swell, say researchers at John Hopkins University School of Medicine, USA. If this is so, we may one day be able to create a test for autism, and perhaps even develop treatment to prevent it.

Egg donors could be paid £1,000, UK   - Nov 17, 2004 11:39 IST
Women who donate their eggs to infertile couples could be paid up to £1,000 under new proposals from the Human Fertilisation and Embryology Authority (HFEA).
Although the sale of gametes is illegal, the EU Tissues and Cells Directive, which comes into force from next April, says donors may receive compensation for the inconvenience of the procedure.


Faith in God is down to your genes, says Researcher   - Nov 17, 2004 11:38 IST
Whether or not you are religious and believe in God is down to your genes, says Dean Hamer, National Cancer Institute’s Gene Structure Regulation Unit, USA. He reckons Jesus, Mohammed (the prophet) and Buddha probably carried the ‘God Gene’ in them. Church representatives have criticised Dean Hamer’s findings.

Arthritis patients ’failed’ by NHS, UK   - Nov 17, 2004 11:38 IST
The NHS is failing to provide adequate support for those suffering with musculoskeletal conditions (MSCs), according to new research.
A study conducted by the Arthritis and Musculoskeletal Alliance (ARMA) found that many patients are being subjected to poor standards of care and provided with little support to help them deal with their condition.


Charities call for smoking ban   - Nov 17, 2004 11:37 IST
The UK’s leading cancer charities are calling on the Government to introduce a full ban on public smoking.
Macmillan Cancer Relief, the Roy Castle Lung Cancer Foundation, the British Lung Foundation and Marie Curie Cancer Care are jointly requesting that England follow the example of Ireland and Scotland and impose an outright smoking ban in enclosed public places such as bars and restaurants.


Reid denies health plans will restrict freedom, UK   - Nov 17, 2004 11:36 IST
The Government aims to protect public health but its plans will not restrict people’s freedom of choice, health secretary John Reid has said.
Tomorrow’s White Paper on public health is expected to suggest how to tackle the increasing problems of childhood obesity and smoking-related illnesses.


Inactive form of scatter factor protein found to suppress tumor growth and spread   - Nov 17, 2004 11:35 IST
Scatter factor (SF) is a growth factor that controls the proliferation and survival of many tissues by promoting invasive growth in both normal and disease-related biological processes.
Produced in a precursor form, pro-SF must be cleaved in order to activate its receptor, Met tyrosine kinase.


Take the Dust Mite Quiz!   - Nov 17, 2004 11:34 IST
To help people learn about and reduce dust mites from their homes, the American Lung Association and ProTeam, maker of high-performance vacuum cleaners, have launched a simple online quiz that will test consumers’ Dust Mite I Q.
With a time limit of 30 seconds per question, visitors quickly choose from multiple-choice answers to questions that test their knowledge about dust mite basics: where they live in your home, what they feed on, how they can affect your breathing, and how to control them. Click here to take the quiz!


MS Patients Benefit from Pumping Iron   - Nov 17, 2004 11:34 IST
Researchers in Melbourne, Australia, have found that exercise can have significant benefits for patients with multiple sclerosis (MS), challenging the conventional medical wisdom.
Doctors normally do not recommend that patients with MS do strenuous exercise.


UN Fails to Reach Compromise on Human Cloning Issue   - Nov 17, 2004 11:32 IST
United Nations diplomats on Thursday said that talks aimed at reaching a compromise on a proposed human cloning ban have failed and, as a result, a General Assembly panel on Friday is expected to vote on the U.S.-supported total cloning ban, Reuters reports (Arieff, Reuters, 11/11).

Combination treatment helps thyroid cancer patients live longer   - Nov 17, 2004 11:32 IST
Combining radiation therapy with surgery and chemotherapy helps patients with rare forms of thyroid cancer live longer, according to a study published in the November 15, 2004, issue of the International Journal of Radiation Oncology*Biology*Physics, the official journal of ASTRO, the American Society for Therapeutic Radiology and Oncology.

Good Intentions Versus Bad Habits: Why the Old Ways Win Out   - Nov 17, 2004 11:31 IST
Why are old habits so hard to break? A new study suggests that over time, our bad habits (such as smoking cigarettes or over eating) become automatic, learned behaviors. Even if we consciously try to put new good intentions into place, those previously learned habits remain stronger in more automatic, unconscious forms of memory.

Ban on TV junk food ads   - Nov 17, 2004 11:30 IST
Adverts for junk foods could be banned from being shown on television before the 9pm watershed as part of a Government strategy to tackle obesity.
Sunday newspaper reports suggest that the proposal will form part of the Government’s Public Health White Paper to be published tomorrow.


Radio tagging drug bottles to combat counterfeiting, USA   - Nov 17, 2004 11:29 IST
Medicine bottles in the USA are going to have miniscule radio antennas (mini masts) as manufacturers try to combat growing counterfeiting of drugs. The antennas will emit radio signals so that the drug companies that make them can keep tags on where they are. The aim is to stop criminals getting hold of the bottles.

How happy are you with your lot in life? New WHO study asks   - Nov 17, 2004 11:28 IST
Researchers are asking people throughout Britain to describe how happy they are with their lot in life to help improve the effect of the healthcare they receive.
The researchers have set up an online survey to collect information on the factors that contribute to the quality of life of people in Britain. (The survey is at: http://www.bath.ac.uk/whoqol/questionnaires).


Continuous Intake of Barley Tea Improves Blood Fluidity   - Nov 17, 2004 11:27 IST
 Japanese food conglomerate Kagome (TSE: 2811) has announced that its research division has confirmed a unique property of barely tea.
According to their latest research, continuous intake of barely tea helps improve the fluidity of blood. Moreover, as the density of alkylpyrazine, a key substance in the tea flavor, increases, the fluidity improves further.



Trusted Consumer Reviews

www.trustsquare.com

©2004: 24x7updates.com. All rights reserved throughout the world.

GenX Campus - Meet, Share & Help fellow Students

Visit Live Punjab for breaking news from Punjab, and Punjabi Community around the world.

Web Hosting India

XBox 360 Cheats, Hints, Walkthroughs and Game Reviews

India | World | Business and Finance | Science and Technology | Software and IT
Health and Science | Sports | Entertainment and Arts